Concepedia

Author

Ami Sabharwal

Cancer Research UK Manchester Institute

Also Known As

A SABHARWAL, A Sabharwal, A. Sabharwal, Ami Sabharwal, Andrew Protheroe

42

Publications

659

Citations

12

H-Index

11

Concepts

All Affiliations

Cancer Research UK Manchester InstituteChurchill HospitalUniversity of OxfordRoyal Marsden NHS Foundation TrustUniversity College London
AS

About

Ami Sabharwal is an author at Cancer Research UK Manchester Institute specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

45

2

Pathology

2

2

45

3

Pharmacology

2

2

45

4

Cancer Therapeutics

1

1

18

5

Hematology

1

1

27

Ami Sabharwal

×

8

Publications

429

Citations

8

H-Index

YearCitations

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

Malcolm Ranson, Peter Hersey, D.M. Thompson,

Journal of Clinical Oncology

2007

110

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Gerhardt Attard, Laura Murphy, Noel W. Clarke,

The Lancet Oncology

2023

85

Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial

Andrew Scarsbrook, David Bottomley, Eugene Teoh,

International Journal of Radiation Oncology*Biology*Physics

2020

63

O6-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib

Amanda J. Watson, M R Middleton, Gail McGown,

British Journal of Cancer

2009

49

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook,

The Lancet

2024

43

Tumor <i>O</i>6-methylguanine-DNA Methyltransferase Inactivation by Oral Lomeguatrib

Amanda J. Watson, Ami Sabharwal, Mary Thorncroft,

Clinical Cancer Research

2010

34

Predicting the myelotoxicity of chemotherapy

Ami Sabharwal, Rachel Waters, Sarah Danson,

Melanoma Research

2010

27

A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer

Ami Sabharwal, Pippa Corrie, Rachel Midgley,

Cancer Chemotherapy and Pharmacology

2009

18

Page 1